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A B S T R A C T
The authors measured the bronchoalveolar lavage fluid (BALF) neutrophils, neu-
trophil elastase and albumin in 60 patients with pulmonary sarcoidosis, 18 patients
with other interstitial lung diseases and 14 healthy controls in order to evaluate its sig-
nificance in the prognosis of sarcoidosis. The concentrations were measured by enzymo-
immunoassay and radial immunodiffusion (LC plates). Obtained values were corre-
lated with some clinical indices, radiological stage and lung function values. The
patients were followed up for 22.3  6.8 months. At the end of observation period the
outcome of sarcoidosis has been evaluated upon the findings of chest radiograms and
lung function tests. The length of duration of the disease correlated with the lung lavage
neutrophil counts (r = 0.2535; p < 0.05). Significantly higher values of BALF elastase
were obtained in III radiologic stage than II and I. Patients with high BALF albumin
had more often dispnoa (p < 0.05) and chronic forms of the disease (p < 0.05). The val-
ues were high in patients in II and III radiologic stage. Unfavorable outcome of chest ra-
diograms was announced by high BALF albumins (p < 0.05). The measurement of
BALF neutrophils, neutrophil elastase and albumin are helpful in clinical management
and estimation of the prognosis in patients with pulmonary sarcoidosis.
Introduction
Sarcoidosis is a multiorganic granulo-
matous disease, which can invade almost
any organ or tissue, but in 95% of the
cases causes lung disease. It is a disease
more common in nonsmokers1, although
most of other pulmonary2 and nonpul-
monary diseases3 are more common in
smokers. The prognosis of pul-monary
sarcoidosis is good but approximately
10–15% of the cases progress to chro-
nicity. Different clinical pictures have
very variable prognosis, so for instance
the acute cutaneous form erythema no-
dosum has 84% remission in two years
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time in contrast to chronic form of lupus
pernio that has only 15%4. The prognosis
of pulmonary sarcoidosis also depends on
initial radiologic stage, hilar (I stage),
hilopulmonary (II stage) or pulmonary
(III stage), the prognosis of III stage be-
ing the worst, with overall 2 years remis-
sion of about 50%5. Lung function tests
show restrictive, sometimes obstructive
ventilatory changes6, and diminished val-
ues of diffusion capacity, the latter being
the omnious prognostic sign7.
The analyses of various components of
bronchoalveolar lavage fluid (BALF)
have been a new tool to estimate the
prognosis of pulmonary sarcoidosis by
measuring at site events. The permanent
inflammation and fibrosis of the pulmo-
nary interstitium and peripheral airspa-
ces are the hallmark of chronic events in
sarcoidosis. This leads to derangement of
the alveolar wall and loss of functional al-
veolar capillary units, resulting in a re-
strictive pattern in lung function tests.
The development of fibrosis rests upon
the activity of various inflammatory cells,
lymphocytes, neutrophils, eosinophils
and mast cells as well as pulmonary vas-
cular leakage of proteins that may acti-
vate lung fibroblasts and initiate deposi-
tion of collagen in the lung interstitium8.
The cell components have been vastly in-
vestigated. The lymphocytic alveolitis in
sarcoidosis is a good prognostic sign, but
the neutrophilic is not and may indicate
chronicity9. Neutrophil elastases are the
products of neutrophils and thus elevated
might also be an omnious sign10. The
raised albumin in lung lavage fluid is not
the artifact due to BAL procedure as it
was thought earlier but this finding is
more likely to be related to the effects of
chronic inflammatory changes in the lung
due to underlying disease that causes in-
creased lung vascular permeability11. The
increased BALF albumin values have
been found in interstitial lung diseases12
and sarcoidosis13, and these finding is in
accordance with on going inflammatory
changes. The prognosis of sarcoidosis is
unpredictable in numerous cases. Our
goal was to investigate whether the mea-
surement of lung lavage neutrophils,
neutrophil elastase and albumin can pre-
dict the outcome of pulmonary sarcoidosis.
Materials and Methods
Sixty patients with biopsy proven pul-
monary sarcoidosis were included in the
study. Al the patients were admitted at
University Hospital for Lung Diseases
»Jordanovac« in Zagreb. We performed
thorough clinical examination with spe-
cial concern for the duration of the dis-
ease prior to admittance, symptoms
(cough, dispnoa), and way of presenta-
tion, acute or initially chronic. In all the
patients chest radiograms and lung func-
tion tests (spirometry, body pletysmogra-
phy and diffusion capacity) were perfor-
med. Bronchoalveolar lavage was done as
a routine procedure at fiberoptic bron-
choscopy. The differential cell count and
biochemical analyses, neutrophil elastase
and albumin of supernatant of lavage
fluid were measured. The patients were
followed up for 22.3  6.8 months (me-
dian 24). At the end of observation period
the outcome of sarcoidosis has been evalu-
ated upon the findings of chest radiograms
and lung function tests. Chest radiograms
and lung function tests (VC-vital capacity,
TLC-total lung capacity, RV-residual vol-
ume and DLCO-diffusion capacity) were
evaluated as normal or pathological at the
end of observation period.
Bronchoalveolar lavage was perfor-
med in accordance with technical recom-
mendations and guidelines of European
Task Group14. The procedure was com-
pleted in a segment of the right middle
lobe with 200 ml isotonic saline. The re-
turned fluid (BALF) was filtered through
two layers of cotton gauze. Differential
cell counts were assessed by numbering
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200 cells, and the results were expressed
as percentage. The biochemical parame-
ters were studied in a supernatant that
remained after the centrifugation of la-
vage fluid. The concentration of neutro-
phil elastase in a complex with  -1-prote-
ase inhibitor (  -Pi) was measured by
commercial enzymoimmunoassay (E.
Merck, Darmstadt). BALF albumin con-
centrations were measured by radial im-
munodiffusion on low concentration pla-
tes (LC) (Behringwerke, Marburg).
The values were expressed as mean
 standard deviation, rarely as median
values. For statistical analyses we used
Chi-square test, Students t test, Wilcox-
Mann-Whitney and Kruskal-Wallis test.
The classical correlation tests and Spear-
mans rang correlations were also per-
formed15.
Results
The experimental group consisted of
60 patients with biopsy proven pulmo-
nary sarcoidosis (S) and two control
groups of 18 patients with other
interstitial lung diseases (I) and 14
healthy persons (HP). Twenty two
sarcoidosis patients were male and 38 fe-
male, with average age of 41.9  12.2
years. Table 1 shows the characteristics
of the groups; there was not statistically
significant difference between the groups
concerning the age, gender or the smok-
ing habits. Twenty three (38.3%) patients
with pulmonary sarcoidosis were at I
radiologic stage, 30 (50%) at II and 7
(11.7%) at III radiologic stage.
All the patients underwent broncho-
alveolar lavage. Table 2 shows the re-
sults. The volume of recovered lavage
fluid was equal in all three groups (S 104
 21.4 ml, I 100.5  18.9 ml and HC
100.7  29.9 ml) as was the percentage of
neutrophils (S 1.9  3.9 %, I 2.2  4 % and
HC 0.6  0.9 %). The concentrations of
neutrophil elastase (S 53.3  56.6 ng/nL,
I 41.4  38.2 ng/mL, HC 20.5  10.2 ng/
mL) (p < 0.05) and albumin (S 74.5  31.6
 g/mL, I 66.5  31.6  g/mL and HC 28.8
 8  g/mL) (p < 0.001) were statistically
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TABLE 1




M F M F
Sarcoidosis N=60 41.9±12.2 22 38 44 16
Interstit. N=18 48.3±13.4 11 7 11 7
Controls N=14 43.9±9.3 7 7 11 3
Difference between groups n.s. n.s. n.s.
TABLE 2
NEUTROPHILS, NEUTROPHIL ELASTASES AND ALBUMIN IN BAL
Sarciodosis Interstit. Controls
VOF (mL) 104±21.4 100.5±18.9 100.7±29.9 n.s.
N (%) 1.9±3.9 2.2±4.0 0.6±0.9 n.s.
NE (ng/mL) 53.3±56.6 41.4±38.2 20.5±10.2 p<0.05
A (µg/mL) 74.5±31.6 66.5±31.6 29.8±8.0 p<0.001
VOF – volume of recovered lung fluid; N – neutrophils; NE – neutrophil elastases; A – albumin.
significantly higher in patients with sar-
coidosis than those of the healthy con-
trols.
We correlated some of the clinical indi-
ces with the results of BALF analyses
(Table 3). The disease that persisted more
than 2 years at the initial examination,
cough and smoking was not correlated
with BALF neutrophils, neutrophil ela-
stase or albumin concentrations. Dispnoa
and chronic initial presentation were cor-
related with high albumin concentrations
(p < 0.05), and necessity for corticoste-
roid therapy with high BALF neutrophils
(p < 0.05) and albumin (p < 0.01). The
BALF experimental indices were obser-
ved in patients in different radiologic
stage, I, II and III. The BALF elastase
showed statistically significant higher
values in the III radiologic stage than in
the I (Figure 1), and BALF albumin con-
centrations were also higher but in the II
(p < 0.01) and the III (p < 0.05) radiologic
stage (Figure 2).
The patients were followed up for
22.3  6.8 months (median 24). Only the
BALF neutrophils showed correlation
with the duration of the disease (p < 0.05)
(Figure 3). Control chest radiograms and
lung function tests assessed the outcome.
Only the high initial values of BALF al-
bumin predicted the poor outcome of
chest radiograms in pulmonary sarcoi-
dosis (p < 0.01) (Figure 4).
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Fig. 1. BALF elastases according to the
radiologic stages.
Fig. 2. BALF albumin according to the
radiologic stages.
TABLE 3
CORRELATION OF CLINICAL DATA WITH INFLAMMATORY BALF INDICES





Duration of the disease > 2 years < 0.05 ns ns ns
Cough < 0.05 ns ns ns
Dispnoa ns ns ns < 0.05
Smoking ns ns ns ns
Chronic presentation ns ns ns < 0.05
Corticosteroid therapy ns < 0.05 ns < 0.01
Ly – lymphocytes; N – neutrophils, ELA – neutrophil elastases; ALB – albumin.
Discussion
Sarcoidosis is a very interesting dis-
ease for investigators because its ethio-
logy, pathogenesis and prognosis are still
unknown. The course of the disease in
most cases is benign and has good prog-
nosis. The drugs of choice are cortico-
steroids16, but they have many unwan-
ted, sometimes very serious side effects.
It is very difficult in some cases to indi-
cate such therapy especially when it is
known that many cases will heal sponta-
neously. One and exact predictive finding
in sarcoidosis does not exist.
The technique of lung lavage has en-
abled us to measure the at site events.
The increased number of BALF neutro-
phils has been suggested to be the sign of
chronicity. We did not find elevated val-
ues in chronic sarcoidosis as some other
already mentioned authors have, but in
the follow up period of approximately two
years we found that the number of BALF
neutrophils increased in time. Drent et
al.9 found that the number of neutrophils
in bronchoalveolar lavage fluid distin-
guish between sarcoidosis patients who
demonstrated remission and those hav-
ing a more sever course. Patients with
higher percentage of BALF neutrophils
in our study were more often treated with
corticosteroids and that also indicates ad-
vanced disease.
The exact role of proteolitic enzymes
in BALF of sarcoidosis patients is not un-
derstood thoroughly, neither that of ela-
stase nor the collagenase. The neutrophil
elastases are increased in BALF accord-
ing to some authors and our findings.
Elastase from neutrophils has been lin-
ked to the pathologic processes of a vari-
ety of inflammatory diseases, for instance
idiopathic pulmonary fibrosis. The serine
proteinase has broad substrate specificity
and may attack a number of host proteins
outside of the neutrophil, including lung
elastin and fibronectin. Such a proteoly-
sis may change the normal surrounding
tissue and protein pattern of an inflam-
matory focus17. The direct measurements
of elastase in granulomatous tissue show
that the enzyme activity increases along
with granuloma maturation and that
they cause the disappearance of elastic
fibres and other elements of matrix18. Ex-
trapolating this data it would be expected
that elevated elastase means tissue dam-
age, but we did not prove that increased
BALF values announce progressive fibro-
tic disease. We showed only that they are
correlated with radiologis stage; the val-
ues are higher in the III stage then in II
and I. Such results correspond with find-
ings of other authors10.
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Fig. 4. Outcome of a chest radiogram accord-
ing to the level of BALF albumines.
Fig. 3. Correlation of BALF neutrophils and
duration of the disease.
The BALF albumin is increased in
sarcoidosis. Clinical signs of chronicity
correlated with high values, it also sho-
wed higher values in more advanced ra-
diologic stages and finely it announced
pathologic chest radiogram at the end of
the study. All these findings show that
the increased values are the sign of chro-
nicity and that they announce progres-
sive, fibrotic disease. We did not find any
study in the literature that evaluated the
correlation of clinical data and high
BALF albumin values in pulmonary sar-
coidosis.
This study was designed to evaluate
the measurements of parameters at the
site of the events, i.e. inside the lungs of
sarcoidosis patients in order to estimate
its prognosis by means of bronchoalveolar
lavage. The increased values of BALF
neutrophils correlated with the duration
of the disease and thus showing its part
in chronic progression. The BALF ela-
stase were higher in more advanced ra-
diologic stage, but did not show correla-
tion with the indices of chronicity. The
BALF albumin measurements were the
most helpful in this respect because they
announced the progressive disease and
pathologic radiograms at the end of ob-
servation. We can conclude that these
measurements are helpful in clinical
judgment and estimation of prognosis in
patients with pulmonary sarcoidosis.
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NEUTROFILNI GRANULOCITI, NEUTROFILNA ELASTAZA I
ALBUMIN U PROGNOZI PLU]NE SARKOIDOZE
S A @ E T A K
Autori su odre|ivali neutrofilne granulocite, neutrofilne elastaze i albumin u bron-
hoalveolarnom lavatu 60 bolesnika s plu}nom sarkoidozom, 18 bolesnika s drugim in-
tersticijskim bolestima plu}a i 14 zdravih ispitanika sa ciljem da utvrde njihov zna~aj u
procjeni prognoze sarkoidoze. Koncentracije su mjerene encimoimunoesejem i radijal-
nom imunodifuzijom. Dobivene vrijednosti korelirane su sa klini~kim pokazateljima,
radiolo{kim stadijem i rezultatima testova plu}ne funkcije. Bolesnici su pra}eni 22.3
 6.8 mjeseci. Na kraju ispitivanja procijenjen je ishod sarkoidoze ma temelju nalaza
radiograma toraksa i plu}nih funkcija. Trajanje bolesti bilo je u pozitivnoj korelaciji s
postotkom neutrofilnih granulocita u lavatu (r = 0.2535; p < 0.05). Signifikantno vi{e
vrijednosti elastaza u lavatu dobivene su u III nego u II i I radiolo{kom stadiju. Bolesnici
s povi{enim albuminima ~e{}e su imali dispneju (p < 0.05) i inicijalno kroni~nu formu
bolesti (p < 0.05). Vi{e su vrijednosti dobivene u II i III radiolo{kom stadiju nego u I.
Povi{ene vrijednosti albumina u lavatu ozna~avale su patolo{ki radiogram plu}a nakon
dvogodi{njeg pra}enja. Mjerenje neutrofilnih granulocita, elastaza i albumina u bron-
hoalveolarnom lavatu je korisno u klini~kom postupku i procjeni prognoze bolesnika s
plu}nom sarkoidozom.
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